neurocoach.
My Care Plan
Explore optionsBrain stimulation

BRAIN STIMULATION

Neupulse and wrist median nerve stimulation

A Tourette research pathway with encouraging trial findings; the current wellness release is distinct from medical-device approval.

NeuroCoach · Evidence explorerSources checked 2026-10-08Editorial draft · clinical review pending

How it works

A wrist-worn device delivers rhythmic electrical stimulation to the median nerve. Trials have studied particular stimulation settings for tics; a generic electrical stimulator is not an equivalent treatment.

What the evidence says, use by use

Evidence is specific to the condition, population and—for devices—the exact product. One label never covers everything.

Tourette Syndrome & Tic Disorders: Reducing tic severity and frequency

Promising
Who was studied / who it’s for: People aged 12+ with Tourette syndrome or chronic tic disorder in a UK trialRegulatory status: Checked October 8, 2026: the manufacturer says medical regulatory work continues and describes a wellness release. Its site ties US/international access to territory-specific approval; US medical availability is not confirmed here.What this label means: Meaningful evidence exists for this use, but important questions remain—about size of benefit, who benefits, or long-term effects.

A randomized sham-controlled trial initially allocated 135 participants and found greater tic reduction with active stimulation after four weeks. A 2026 follow-up reports persistence in the active group, but does not provide a continuing blinded between-group comparison at three months.

Sources: Morera Maiquez et al., Journal of Neuropsychology (2023) · Journal of Neuropsychology (2026) · Neupulse manufacturer; status checked October 8, 2026 · Neupulse manufacturer; status checked October 8, 2026 · Neupulse manufacturer; status checked October 8, 2026

Who usually provides it

Discuss with a neurologist or clinician experienced in Tourette syndrome and tic disorders.

Cautions & things to know

  • A wellness product, preorder or overseas release does not establish FDA clearance for Tourette treatment.
  • Ask about current device contraindications, interactions with implanted devices, skin/sensory tolerability and monitoring. Do not change medicines on the basis of a product announcement.
  • Trial findings do not establish this as treatment for every co-occurring symptom; keep CBIT and other established options in the discussion.

Questions for a clinician

Conversation prompts, not a treatment plan.

  • What is the current US regulatory and access status?
  • What meaningful tic-related goal would we measure?
  • Is there a legitimate study, and what are the costs, limitations and alternatives?

Educational, not medical advice. NeuroCoach is an educational and care-navigation resource, not a medical provider. Information about medications, supplements, therapies, devices, clinical trials and community experiences is provided for education and exploration and is not a recommendation, diagnosis or treatment plan. Evidence varies substantially among interventions. Decisions about medical or mental-health treatment should be made with an appropriately qualified healthcare professional. Do not start, stop or change medication, supplements or treatment based solely on information found here.

Sources

Sources checked 2026-10-08. Educational editorial draft; clinical review pending.

  1. Sham-controlled trial of home-administered median nerve stimulation for tics Morera Maiquez et al., Journal of Neuropsychology (2023)
  2. Three-month follow-up in the active median nerve stimulation group Journal of Neuropsychology (2026)
  3. Clinical development and ongoing medical-device regulatory pathway Neupulse manufacturer; status checked October 8, 2026
  4. Wellness release update Neupulse manufacturer; status checked October 8, 2026
  5. Availability and international access FAQ Neupulse manufacturer; status checked October 8, 2026